Investor Alert

HilleVax Inc.



After Hours

 --Quotes are delayed by 20 min

Jun 9, 2023, 4:10 p.m.





+0.16 +0.91%


Volume 694

Quotes are delayed by 20 min


Previous close

$ 17.77

$ 17.59


-0.18 -1.01%

Day low

Day high




52 week low

52 week high




Aditya Kohli

Founder of Phathom Pharmaceuticals, Inc., Passage Bio, Inc., Scout Bio, Inc. and Recida Therapeutics, Inc., Aditya Kohli is an entrepreneur who currently holds the position of Chief Operating Officer & Director at HilleVax, Inc., Chief Business Officer for Phathom Pharmaceuticals, Inc. and Venture Partner at Frazier Management LLC. He is also on the board of Scout Bio, Inc. and Vice President for Frazier Life Sciences IX LP.

In the past Dr. Kohli held the position of Engagement Manager at McKinsey & Co., Inc.

He received an undergraduate degree and a graduate degree from Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.


Date Shares Transaction Value
02/01/2023 85,466   Award at $0 per share. 0

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. Shane Maltbie
Chief Financial Officer
Dr. Astrid Borkowski
Chief Medical Officer
Dr. Anju Chatterji
Chief Technology Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Mr. David A. Socks
Chief Business Officer
Mr. Ozzie Berger
Senior Vice President-Regulatory Affairs
Dr. Nanette Cocero
Independent Director
Dr. Gary Dubin
Independent Director
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Link to MarketWatch's Slice.